Assenagon Asset Management
COLL icon

Assenagon Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Assenagon Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
308,917
-3,681
-1% -$126K 0.01% 513
2026
Q1 		$10.3M Sell
312,598
-199,100
-39% -$8.43M 0.02% 453
2025
Q4 		$23.7M Buy
511,698
+316,109
+162% +$13.2M 0.03% 335
2025
Q3 		$6.84M Buy
195,589
+92,898
+90% +$3.23M 0.01% 557
2025
Q2 		$3.04M Hold
102,691
– – ﹤0.01% 666
2025
Q1 		$3.07M Sell
102,691
-47,897
-32% -$1.46M 0.01% 655
2024
Q4 		$4.31M Sell
150,588
-23,126
-13% -$765K 0.01% 725
2024
Q3 		$6.71M Sell
173,714
-188,423
-52% -$6.72M 0.01% 634
2024
Q2 		$11.7M Buy
362,137
+291,286
+411% +$10.1M 0.03% 407
2024
Q1 		$2.75M Sell
70,851
-274,989
-80% -$9.62M 0.01% 766
2023
Q4 		$10.6M Sell
345,840
-79,790
-19% -$2M 0.03% 436
2023
Q3 		$9.51M Buy
425,630
+272,565
+178% +$6.22M 0.03% 392
2023
Q2 		$3.29M Sell
153,065
-105,625
-41% -$2.4M 0.01% 600
2023
Q1 		$6.21M Buy
258,690
+125,956
+95% +$3.34M 0.02% 516
2022
Q4 		$3.08M Buy
132,734
+117,900
+795% +$2.38M 0.01% 669
2022
Q3 		$238K Sell
14,834
-35,564
-71% -$627K ﹤0.01% 1258
2022
Q2 		$893K Hold
50,398
– – ﹤0.01% 1108
2022
Q1 		$1.03M Buy
+50,398
New +$952K ﹤0.01% 1042

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Assenagon Asset Management's COLL Position: Q2 2026 in Review

Assenagon Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 1.2% in Q2 2026, selling an estimated $126K and leaving 308,917 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #513.

Assenagon Asset Management first reported a position in COLL in Q1 2022 and has held it in 18 quarters since. The position peaked at $23.7M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Assenagon Asset Management held 308,917 shares of Collegium Pharmaceutical worth $11.2M as of Q2 2026.
  • Assenagon Asset Management sold 3,681 Collegium Pharmaceutical shares in Q2 2026, an estimated $126K.
  • Collegium Pharmaceutical made up 0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #513 holding.
  • Assenagon Asset Management first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
  • Assenagon Asset Management's Collegium Pharmaceutical position peaked at $23.7M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.